Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.120 | 13 | 40605661 | intron variant | A/G | snv | 0.38 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
0.882 | 0.120 | 13 | 40605661 | intron variant | A/G | snv | 0.38 |
|
Neoplasms | 0.700 | 1.000 | 2 | 2018 | 2019 | |||||||
|
13 | 40642397 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
13 | 40642397 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||||
|
13 | 40599271 | intron variant | G/A;C | snv |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||||||||
|
13 | 40650151 | intron variant | TATA/- | delins | 0.41 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
13 | 40586133 | intron variant | T/C | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
13 | 40586133 | intron variant | T/C | snv | 0.20 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 13 | 40643068 | intron variant | G/A | snv | 0.21 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.240 | 13 | 40565740 | intron variant | G/A | snv | 0.16 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2009 | 2017 | |||||||
|
0.851 | 0.240 | 13 | 40565740 | intron variant | G/A | snv | 0.16 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2017 | 2019 | |||||||
|
0.925 | 0.120 | 13 | 40659794 | intron variant | A/G | snv | 0.41 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.020 | 1.000 | 2 | 2009 | 2015 | |||||||
|
1.000 | 0.080 | 13 | 40612364 | intron variant | G/A | snv | 0.17 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.240 | 13 | 40565740 | intron variant | G/A | snv | 0.16 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.851 | 0.240 | 13 | 40565740 | intron variant | G/A | snv | 0.16 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.240 | 13 | 40565740 | intron variant | G/A | snv | 0.16 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.200 | 13 | 40557795 | 3 prime UTR variant | C/T | snv | 3.7E-02 |
|
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.200 | 13 | 40557795 | 3 prime UTR variant | C/T | snv | 3.7E-02 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 13 | 40659865 | intron variant | T/C | snv | 0.12 |
|
Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.080 | 13 | 40659865 | intron variant | T/C | snv | 0.12 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.925 | 0.120 | 13 | 40659794 | intron variant | A/G | snv | 0.41 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.925 | 0.120 | 13 | 40659794 | intron variant | A/G | snv | 0.41 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 13 | 40565575 | intron variant | T/C | snv | 0.38 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 13 | 40565575 | intron variant | T/C | snv | 0.38 |
|
Pathological Conditions, Signs and Symptoms; Infections | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.882 | 0.160 | 13 | 40565575 | intron variant | T/C | snv | 0.38 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 |